SOURCES SOUGHT
66 -- Rapid Microbial Detection and Enumeration System Upgrade - Sources Sought 1142858
- Notice Date
- 12/24/2014
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- 1142858
- Archive Date
- 1/20/2015
- Point of Contact
- Sondea R Blair, Phone: 8705437469
- E-Mail Address
-
sondea.blair@fda.hhs.gov
(sondea.blair@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Sources Sought 1142858 MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION This is a sources sought to determine the availability and capability of small businesses in providing services to upgrade the operating system of a Rapid Microbial Detection and Enumeration System with subsequent Installation Qualification (IQ) and Operational Qualification (OQ) as well as post-upgrade Preventive and Corrective Maintenance Services. The associated North American Industry Classification System (NAICS) Code is 334516- Analytical Laboratory Instrument Manufacturing; Small Business Size Standard is 500 employees. Part I: General Information (Introduction/Background/Scope) The U.S. Food and Drug Administration (FDA) is conducting market research to support the Center for Biologics Evaluation and Research (CBER) requirement for an upgrade of a computer operating system for an existing Rapid Microbial Detection and Enumeration System manufactured by EMD Millipore (serial number 374620) with installation qualification (IQ) and operational qualification (OQ) testing, and up to five (5) 1-Year periods for Preventive and Corrective Maintenance Services on the upgraded Rapid Microbial Detection and Enumeration System. The FDA's Division of Biological Standards and Quality Control (DBSQC) serves as a Standards Preparation and Quality Testing laboratory for CBER. DBSQC is also an ISO 17025 accredited quality testing laboratory of CBER. The Government uses the Rapid Microbial Detection and Enumeration System in mission critical testing for regulatory decisions to support product licensure, lot release, and other regulatory decisions for the determination of sterility in vaccines and other biological products such as the influenza vaccine. Part II: Supporting Information A. Place of Performance U.S. Food and Drug Administration Federal Research Center White Oak Building 52/72 10903 New Hampshire Avenue Silver Spring, MD 20993 B. Period of Performance System upgrade, IQ/OQ shall be completed within 120 calendar days (or sooner) from date of award. Part III: Instructions to Prospective Respondents The offeror shall furnish sufficient information necessary for the Government to conclusively determine that the respondent is capable and otherwise qualified to perform the full range of services identified herein. At a minimum, responses shall include the following: ~Business name and bio, DUNS number, business address, business website, business size status (i.e., SB, VOSB, SDVOSB, HUBZone SB, 8(a), SDB, WOSB, EDWOSB, LB), point of contact name, mailing address (if different from business address), phone number and email address; ~Past performance information for the full range of upgrade, IQ/OQ, and preventive and corrective maintenance services identified herein for the same or substantially similar OEM equipment, to include date of services, description (should also include technical literature and specifications), dollar value, client name, client address, client point of contact name, client point of contact mailing address (if different from that provided for client), client point of contact phone number, client point of contact email address, and name of the manufacturer (to include DUNS number and size status) if not the respondent; ~Descriptive literature, brochures, specifications, marketing material, etc. detailing the nature of the services the responding firm is regularly engaged in providing; ~If applicable, identification of the firm's GSA Schedule contract(s) by Schedule number and SINs that are applicable to this requirement; ~Although this is not a request for quote, informational pricing is encouraged; The Government encourages any comments and/or suggestions from any interested party, regarding the specifications. While the Government will not respond directly to your comments and/or suggestions; we will consider them as we finalize the specifications in preparation for the forthcoming solicitation. The Government is not responsible for locating or securing any information, not identified in the response. Interested parties must respond with capability statements, which are due in person, by postal mail or email to the point of contact listed below on or before January 05, 2015 29, 2014 by 9:00 AM (Central Time in Jefferson, Arkansas) at the Food and Drug Administration, OO|OFBA|OAGS|DAP, Attn: Sondea Blair, 3900 NCTR Road, Bldg 50/Room 421, HFT‐320, Jefferson, AR 72079‐9502 or email sondea.blair@fda.hhs.gov. Reference Number 1142858 in all correspondence with the point of contact listed above. Notice of Intent Responses to this sources sought announcement will assist the Government in determining whether this requirement should be set aside for small business, made available to full and open competition or procured through other than full and open acquisition procedures. Disclaimer and Important Notes This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a combined synopsis/solicitation (No. FDA-15-223-SOL-1142858) may be published via FedBizOpps. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/1142858/listing.html)
- Place of Performance
- Address: U.S. Food and Drug Administration, Federal Research Center, White Oak Building 52/72, 10903 New Hampshire Avenue, Silver Spring, Maryland, 20993, United States
- Zip Code: 20993
- Zip Code: 20993
- Record
- SN03604789-W 20141226/141224233908-12076ebcc54596d186f3cbde63ca2285 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |